Latest filing published 07 Dec 2022 for NovaBay Pharmaceuticals, Inc., €2.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Audrey Kunin, listed as senior executive, appears in our data through filings on Stablecoin Development Corp shares, published by SEC (Form 4). We count 10 filings; the first trade dates from 22 November 2021 and the latest from 6 December 2022.
On the open market, the record shows 6 purchases worth €208k and 4 sales worth €70k. Netting one side against the other leaves €137k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2022 to date brings no purchases and 4 sales.
A typical purchase (the median) is worth €20k. Of 6 purchases, 6 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -21.3%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 7 December 2022 with an open-market sale (€2) in Stablecoin Development Corp. The last insider purchase was made public on 7 December 2021, 1,782 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 4 declarations